CELCMID

Celcuity Inc.

HealthcareBiotechnology
$99.95
$0.04(+4.19%)
52W$12.48
$151.02
Updated Jun 28, 02:00 AM
RSI43
RS Rating65/99
Beta1.37
Volatility74%
F-Score3/9
Mkt Cap$4.9B
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Celcuity Inc. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is moderate (RS Rating: 65), indicating performance broadly in line with the market. Earnings contraction of 13% provides fundamental context to the price action. Investors should exercise caution due to high volatility (74% annualized), which requires wider risk management.

Relative Strength
65
out of 99
Average
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
1.37
vs S&P 500
ABOVE MKT
52W Position
63%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$115.36
50 SMA > 100 SMA$113.20
100 SMA > 150 SMA$110.13
150 SMA > 200 SMA$98.30

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$94.35+5.93%ABOVE
50 SMA$115.36-13.36%BELOW
100 SMA$113.20-11.70%BELOW
150 SMA$110.13-9.24%BELOW
200 SMA$98.30+1.68%ABOVE

Price Performance

1D+4.2%
1W+11.1%
1M-25.6%
3M-12.9%
6M-2.2%
YTD-0.6%
1Y+7.3%
3Y+101.7%
52-Week Trading Range63% from low
$99.95
52W Low$12.48
52W High$151.02

Technical Indicators

RSI (14)NEUTRAL
43.3
305070
Setup ScoreCOOL
5/10
Base depth: 68.5%

Risk Profile

Beta
1.37
52W Vol
74%
ATR
$5.43
Max DD (1Y)
-40%

Volume Analysis

Today
50D Avg
1.32M
Vol Ratio
0.00x
Liquidity
LIQUID

Earnings Momentum

Q2'25-68%
$-1.04
Q3'25-31%
$-0.92
Q4'25-13%
$-0.96
Q1'26-13%
$-0.97
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:-26.51%
5 Years:
3 Years:
TTM:-28.38%

Stock Price CAGR

10 Years:+21.47%
5 Years:+26.44%
3 Years:+101.70%
1 Year:+7.32%

Return on Equity

10Y Avg:-62.8%
5Y Avg:-82.3%
3Y Avg:-99.3%
Last Year:-244.6%

Key Metrics

Market Cap$4.9B
Gross Margin
Net Margin
Piotroski F-Score3/9

Frequently Asked Questions

Is CELC in an uptrend right now?

CELC has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is CELC overbought or oversold?

CELC's RSI (14) is 43. The stock is in neutral territory, neither overbought nor oversold.

Is CELC outperforming the market?

CELC has a Relative Strength (RS) Rating of 65 out of 99. CELC is performing about average compared to the market.

Where is CELC in its 52-week range?

CELC is trading at $99.95, which is 66% of its 52-week high ($151.02) and 63% above its 52-week low ($12.48).

How volatile is CELC?

CELC has a Beta of 1.37 and 52-week volatility of 74%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.